Detalles de la búsqueda
1.
Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer.
Nature
; 620(7973): 409-416, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37532934
2.
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 25(5): 572-587, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38561010
3.
Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer.
Oncologist
; 28(12): e1209-e1218, 2023 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37597246
4.
Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study.
Invest New Drugs
; 41(5): 677-687, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37556023
5.
A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study.
BMC Cancer
; 23(1): 393, 2023 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37131154
6.
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol
; 22(4): 463-475, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33684370
7.
Improving patient selection for immuno-oncology phase 1 trials: External validation of six prognostic scores in a French Cancer Center.
Int J Cancer
; 148(10): 2502-2511, 2021 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33231298
8.
Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study.
Lancet Oncol
; 21(9): 1155-1164, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32771088
9.
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study.
Lancet Oncol
; 21(10): 1353-1365, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32919526
10.
Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study.
Lancet Oncol
; 21(9): 1173-1187, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32758455
11.
Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial.
Lancet Oncol
; 21(5): 645-654, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32224306
12.
Phase 1 study of the immunotoxin LMB-100 in patients with mesothelioma and other solid tumors expressing mesothelin.
Cancer
; 126(22): 4936-4947, 2020 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32870522
13.
A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients with advanced solid tumours.
Br J Cancer
; 123(10): 1481-1489, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32839491
14.
Modernizing adverse events analysis in oncology clinical trials using alternative approaches: rationale and design of the MOTIVATE trial.
Invest New Drugs
; 38(6): 1879-1887, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32383099
15.
A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment.
Invest New Drugs
; 38(6): 1774-1783, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32410080
16.
Improving communication between the general practitioner and the oncologist: a key role in coordinating care for patients suffering from cancer.
BMC Cancer
; 20(1): 495, 2020 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32487036
17.
Circulating Tumor Cells as a Prognostic Factor in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: The CIRCUTEC Prospective Study.
Clin Chem
; 65(10): 1267-1275, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31387885
18.
First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors.
Invest New Drugs
; 37(4): 674-683, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30411218
19.
Phase I dose-escalation study of F14512, a polyamine-vectorized topoisomerase II inhibitor, in patients with platinum-refractory or resistant ovarian cancer.
Invest New Drugs
; 37(4): 693-701, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30547316
20.
Definitive radiochemotherapy or initial surgery for oropharyngeal cancer : To what extent can p16 expression be used in the decision process?
Strahlenther Onkol
; 195(6): 496-503, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30877351